Andon Health Co., Ltd.
↗Tianjin, China
Andon Health Co., Ltd. is a China-based company founded in 1995 that specializes in the research, development, manufacturing, and distribution of medical instruments and smart health hardware. Its product portfolio includes blood pressure monitors, blood glucose monitors, TENS units, electrical muscle stimulators, digital thermometers, and other home-care medical devices.
The company is publicly traded on the Shenzhen Stock Exchange (SHE: 002432) and has expanded its operations internationally, including a significant presence in the U.S. market through its subsidiary, iHealth. In addition to its core medical device business, Andon Health is active in private equity and venture capital investments within the healthcare and TMT sectors.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Home Healthcare Equipment
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B-$2B
Founded:1995
Ownership:public
Status:operating
FUNDING
Investors:IDG Capital
STOCK
Exchange:Shenzhen Stock Exchange
Ticker:002432
Market Cap:$5.47B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Medical Devices, Digital Health
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:iHealth
Key Partnerships:American ACC (Distribution partnership)
COMPETITION
Position:Leader
Competitors:Omron Healthcare, Sanuo Biology, Yuyue Medical
LEADERSHIP
Key Executives:
Yi Liu - Chairman & GM
LINKS
Website:jiuan.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Andon Health Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Andon Health Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.